Haoyuan Pharmaceutical funding history / development milestones

IPO上市,

2021.06.08,上交所

Note: collected from public online reports, for reference only.

People who follow Haoyuan Pharmaceutical also follow

Haoyuan Pharmaceutical Competitors (Similar Companies)

生物科技/生物工程 医药 生物医药 高通量测序
“To develop high-quality biologics that are accessible and affordable f”
制药/药业 生物制药 医药 生物科技/生物工程
“抗体偶联药物(ADC)等生物偶联药端到端服务”
“Promoting human health”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“To provide patients with trustworthy and affordable innovative biologi”
“Primarily engaged in the research and development, production, and sal”
“Pharmaceutical Custom R&D and Manufacturing”
“连续多年位居国内皮肤临床用药领导地位”
“In the rapidly growing biopharmaceutical field, accelerate and transfo”
“Virtue over the world, medicine benefits all”
“Caring for life, maintaining health”
生物制品 疫苗 抗生素 中成药
“Creating a sustainable and brighter future together”